BB&T Securities LLC lowered its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 16.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 74,826 shares of the medical research company’s stock after selling 15,011 shares during the quarter. BB&T Securities LLC’s holdings in Thermo Fisher Scientific were worth $13,055,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the company. Northeast Investment Management increased its stake in shares of Thermo Fisher Scientific by 10.1% in the second quarter. Northeast Investment Management now owns 113,116 shares of the medical research company’s stock worth $19,735,000 after acquiring an additional 10,369 shares during the period. ZWJ Investment Counsel Inc. increased its stake in shares of Thermo Fisher Scientific by 34.3% in the second quarter. ZWJ Investment Counsel Inc. now owns 63,228 shares of the medical research company’s stock worth $11,031,000 after acquiring an additional 16,148 shares during the period. Penobscot Investment Management Company Inc. acquired a new stake in shares of Thermo Fisher Scientific in the second quarter worth $250,000. Hartland & Co. LLC increased its stake in shares of Thermo Fisher Scientific by 12.3% in the second quarter. Hartland & Co. LLC now owns 2,925 shares of the medical research company’s stock worth $510,000 after acquiring an additional 320 shares during the period. Finally, Everett Harris & Co. CA increased its stake in shares of Thermo Fisher Scientific by 3.9% in the second quarter. Everett Harris & Co. CA now owns 13,127 shares of the medical research company’s stock worth $2,290,000 after acquiring an additional 492 shares during the period. Hedge funds and other institutional investors own 83.36% of the company’s stock.

In other news, SVP Gregory J. Herrema sold 30,000 shares of the company’s stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $176.02, for a total transaction of $5,280,600.00. Following the transaction, the senior vice president now directly owns 67,016 shares of the company’s stock, valued at approximately $11,796,156.32. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jim P. Manzi sold 1,000 shares of the company’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $175.20, for a total transaction of $175,200.00. Following the transaction, the director now directly owns 38,757 shares in the company, valued at $6,790,226.40. The disclosure for this sale can be found here. Insiders sold a total of 52,738 shares of company stock worth $9,302,112 over the last three months. 0.49% of the stock is currently owned by corporate insiders.

A number of analysts have recently weighed in on TMO shares. Deutsche Bank AG set a $200.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Saturday, June 10th. BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. Citigroup Inc. reiterated a “buy” rating and issued a $201.00 price objective (up previously from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 price objective on the stock in a research note on Tuesday, July 11th. Finally, Wells Fargo & Company reiterated an “outperform” rating and issued a $200.00 price objective (up previously from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. One analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific presently has a consensus rating of “Buy” and an average target price of $200.79.

WARNING: This piece was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/28/bbt-securities-llc-cuts-stake-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Inc (TMO) opened at 188.47 on Thursday. The firm’s 50-day moving average is $181.07 and its 200 day moving average is $171.15. The stock has a market capitalization of $73.53 billion, a P/E ratio of 32.83 and a beta of 1.05. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. Thermo Fisher Scientific’s revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.03 EPS. Equities analysts expect that Thermo Fisher Scientific Inc will post $9.34 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be paid a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 annualized dividend and a yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.45%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.